Pulpitis
Conditions
Interventions
This is a double-blind, placebo-controlled clinical trial. A total of sixty volunteers with mild to severe preoperative pain will be randomly divided into three groups (n=20 per group): DI – dexamenta
Sponsors
Fundação Francisco Mascarenhas/Faculdade Integradas de Patos-FIP
Universidade Federal de Campina Grande
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Systemically healthy patients of any gender aged between 18 and 65 years; teeth diagnosed with symptomatic or asymptomatic irreversible pulpitis and symptomatic apical periodontitis (presence of preoperative pain); and preoperative pain ranging from mild to severe on the Heft Parker visual analogue scale
Exclusion criteria
Exclusion criteria: Pregnant or breastfeeding women; patients with allergies, sensitivity or adverse reactions to dexamethasone or ibuprofen; individuals who received any analgesic or anti-inflammatory in the last 12 hours before treatment; and non-restorable teeth, with periodontal disease, root resorption, open apex and calcified root canals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to reduce postoperative endodontic pain within 7 days with the combined use of ibuprofen and dexamethasone | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to see an increase in the anesthetic success rate and improvement in postoperative quality of life within 7 days with the combined use of ibuprofen and dexamethasone | — |
Countries
Brazil
Contacts
Public ContactFelipe Matos
Universidade Federal de Campina Grande
Outcome results
None listed